BACKGROUND AND PURPOSE
Introduction
Acetylcholine is a classical neurotransmitter in the peripheral and central nervous systems. In the intestine, the main source of neuronal acetylcholine is the enteric nervous system formed by the submucosal and myenteric plexus. Two classes of receptors mediate the action of acetylcholine: G protein-coupled muscarinic receptors, of which five subtypes (M 1 to M 5 ) are known (Caulfield and Birdsall, 1998) , and different types of homo-or heteropentameric nicotinic receptors, which, in general, function as ligandgated ion channels (Albuquerque et al., 2009) . It is generally thought that nicotinic receptors mediate the effect of acetylcholine on excitable tissues such as neurons or skeletal muscle. In contrast, muscarinic receptors are observed preand postsynaptically in neurons, and they mediate the action of this transmitter in organs or tissues innervated by the autonomous nervous system. For example, in the gut, M 1 receptors are found on epithelial cells (Haberberger et al., 2006, Wessler and Kirkpatrick, 2008) and on enteric neurons (North et al., 1985) , M 2 receptors on smooth muscle cells (Bhattacharya et al. 2013) and M 3 receptors on epithelial and smooth muscle cells (Wessler and Kirkpatrick, 2008) .
This classical view of cholinergic signal transduction has been challenged by recent observations. For example, nonneuronal cells, mainly with barrier or defence function, that is, epithelial and immune cells, also synthesize and release acetylcholine (Wessler et al., 2003, Wessler and Kirkpatrick, 2008) . Also, rat colonic surface epithelium synthesizes acetylcholine and releases it as a paracrine mediator after contact with the short-chain fatty acid propionate (Yajima et al., 2011) via transporters of the organic cation transporter family (Bader et al., 2014) . Besides acetylcholine, this tissue also synthesizes other choline esters such as propionylcholine or butyrylcholine, which stimulate cholinergic receptors and contribute to local signalling within colonic epithelium (Moreno et al., 2016) .
A further modification of the textbook view on cholinergic signalling results from the expression of nicotinic receptors in non-excitable tissue such as epithelia. For example, in murine tracheal epithelium, nicotinic receptors are involved in the regulation of the production of airway lining fluid (Hollenhorst et al., 2012) . Also, colonic epithelium expresses -besides muscarinic receptors of the M 1 and the M 3 subtype (Haberberger et al., 2006, Bader and Diener, 2015) -different subunits of nicotinic receptors (α2, α4, α5, α6, α7, α10 and β4), and stimulation of these receptors with nicotinic agonists induces a Cl À secretion (Bader and Diener, 2015) . In contrast to stimulation of muscarinic receptors, which activates anion secretion via hyperpolarization of the membrane due to opening of basolateral (and apical) Ca 2+ -dependent K + channels (Strabel and Diener, 1995) and transient stimulation of apical Ca 2+ -dependent Cl À channels (Hennig et al., 2008) , nothing is known about the mechanism of action of nicotinic receptors in intestinal epithelium. Therefore, in the present study, we measured transepithelial currents and selective currents across the apical or the basolateral membrane in rat distal colon in order to identify the ion transporters, which are activated by nicotinic receptors and their potential interaction with muscarinic receptors during regulation of transepithelial transport.
Methods

Animals
All animal care and experimental procedures were approved by the named animal welfare officer of the Justus Liebig University (administrative number 577_M) and performed according to the German and European animal welfare law. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Wistar rats (160-250 g) were used in these experiments. Both female and male rats were used in about equal number (overall 45% males, 55% females) with random distribution of the sex of the used animals within the individual experimental groups. The animals were bred and housed at the Institute of Veterinary Physiology and Biochemistry of the Justus-Liebig-University with free access to food and water until the time of experiment. Animals were housed in macrolone type IV cages with three animals per cage at 22°C, 50% air humidity and a light : dark cycle of 12:12 h. Animals were killed after CO 2 narcosis, by cervical dislocation followed by exsanguination. 
Tissue preparation
Rat distal colon, which is a well-established model to study epithelial anion secretion, was quickly removed and placed in ice-cold Ussing chamber bathing solution. The large intestine was carefully flushed several times before it was mounted on a thin plastic rod. A circular incision was made near the distal end with a blunt scalpel. The serosa and muscularis propria were stripped off by hand in order to obtain a mucosa-submucosa preparation. Two segments from distal colon were prepared from each animal; in general, one segment served as control to study the response to a nicotinic agonist in the absence and the other segment to study the response in the presence of putative inhibitors. Segments were randomly distributed by a technician; blinding did not seem to be appropriate for these in vitro experiments.
Ussing chamber experiments
The mucosa-submucosa preparations were fixed in a modified Ussing chamber, bathed with a volume of 3.5 mL on each side. (Catterall, 1980) . The maximal increase in I sc evoked by an agonist is given as the difference from the baseline value, just prior administration of the drug. In those experiments, where the I sc did not stabilize, that is, the administration of drugs during the decaying phase of the nystatin-induced I sc , the theoretical course of I sc was calculated by linear regression analysis as described previously (Schultheiss and Diener, 1997) . To do so, the I sc 3 min prior administration of the drug (30 data points, as I sc was registered every 6 s) was used to calculate the regression line. This regression served to extrapolate the decay of I sc in the absence of nicotine, which was subtracted from the maximal increase in I sc evoked by nicotine.
When a drug (which evoked reproducible effects after repeated administration) was administered repeatedly to the same tissue (as in the experiments shown in Figure 6B ), the compartment to which the substance had been administered was washed three times with 5× the chamber volume, before the drug was administered again.
Data and statistical analysis
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Results are given as mean ± SEM with the number (n) of investigated tissues. For all Ussing chamber experiments, a group size of n = 6-7 was designed; in some experimental series, it was increased up to nine, if there was a larger variability. For the comparison of two groups, either Student's t-test or Mann-Whitney-Utest was applied. An F-test decided which test method had to be used. Both paired and unpaired two-tailed Student's t-tests were applied as appropriate. When means of more than two groups had to be compared, ANOVA was used. If there was no significant variance inhomogeneity and an F-test indicated that variances between the groups were significantly larger than within the groups, a Tukey post hoc test was performed. P < 0.05 was considered to be statistically significant. Statistical comparisons were performed using the statistical software Winstat 2012.1 (R. Fitch Software, Bad Krozingen, Germany). Linear regressions were calculated with Excel 2010 (Microsoft, Redmond, WA, USA).
Materials
Bumetanide, forskolin and mecamylamine were dissolved in ethanol (final maximal ethanol concentration 0.5 mL·L À1 ).
Scilliroside (gift from Sandoz, Basel, Switzerland) was dissolved in methanol (final methanol concentration 2 mL·L À1 ). Dihydro-β-erythroidine (DhβE; Tocris, Bristol, UK) and ouabain were dissolved in DMSO (final maximal DMSO concentration 1 mL·L À1 
Results
Nicotinic receptors do not activate apical ion channels
As nicotine induces Cl À secretion (Bader and Diener, 2015) , which centrally involves Cl À efflux via anion channels in the apical membrane (Barrett and Keely, 2000) , we needed to know if stimulation of nicotinic receptors leads to activation of a Cl À conductance in the apical membrane. A chemical permeabilization of the basolateral membrane by ionophores, for example, by nystatin, is not possible in our hands as ionophores do obviously not pass the tissue layers underlying the epithelium in sufficient amounts. Therefore, the basolateral membrane was 'electrically eliminated' by depolarization with a buffer containing a high K + concentration. Due to the high basolateral K + permeability, the electrical properties of the tissue, which are normally characterized by two batteries in series, are then dominated by the apical membrane (Fuchs et al., 1977, Schultheiss and Diener, 1997) . A Cl À concentration gradient (111.5 mmol·L
À1
KCl at the serosal side, 111.5 mmol·L À1 K gluconate at the mucosal side) served as driving force for Cl À flux across apical anion channels (see schematic inset in Figure 1 ). This series of experiments and all subsequently described experiments were performed in the continuous presence of the neurotoxin TTX (10 À6 mol·L À1 at the serosal side) in order to prevent effects of nicotine mediated by cholinergic receptors on secretomotor neurons of the enteric nervous system. However, under these conditions, nicotine (10
at the serosal side; for a complete concentration-response curve describing the effect of nicotine on Cl À secretion across rat colonic epithelium, see Bader and Diener, 2015) was completely ineffective ( Figure 1 ). As positive control, at the end of the experiment, the activator of adenylate cyclase(s) forskolin (5·10 À6 mol·L
at the mucosal and the serosal side) was administered, which induced a prompt positive I sc , as expected, when the cystic fibrosis transmemembrane regulator, that is, the dominant anion channel in the apical membrane of colonic epithelium (Verkman and Galietta, 2013) , is activated by cAMPdependent phosphorylation. 
Activation of electrogenic ion transport across the basolateral membrane by nicotine
In order to find out whether the site of action of nicotinic receptors is electrogenic ion transporters in the basolateral membrane, the apical membrane was permeabilized by the ionophore nystatin (100 μg·mL À1 at the mucosal side). In a first step, buffer solutions were selected, which allowed both a flux of K + ions across basolateral K + channels by applying
Figure 1 Figure 2 ). As described previously, nystatin induced a strong stimulation of I sc under these conditions, which slowly fades over time (Schultheiss and Diener, 1997 Figure 4 ), nicotine (10 À4 mol·L À1 at the serosal side) induced a strong increase in I sc across the basolateral membrane in apically permeabilized epithelia ( Figure 4A ). The nicotine-induced current was nearly suppressed in the presence of scilliroside (10 À4 mol·L À1 at the serosal side; Figure 4B , Table 1 ), which effectively blocks the Na + -K + -ATPase from rats (Robinson, 1970) . A weaker, but statistically significant, inhibition was also observed, when the epithelium was pretreated with ouabain (Table 1) , the prototypical inhibitor of the Na + -K + -pump, for which the rat α 1 subunit [that forms -together with a β 1 subunit -the dominant form of this transport enzyme in rat intestine (Escoubet et al., 1997) ] is known to be less sensitive in comparison with other species (Blanco and Mercer, 1998) . Taken together, the cation substitution experiments combined with these blocker experiments clearly indicate that the nicotine-induced I sc is carried by the basolateral Na + -K + -ATPase.
Characterization of the receptors involved in the stimulation of pump current induced by nicotine
In order to investigate, whether the action of nicotine on pump current is indeed mediated by nicotinic receptors, the colonic epithelium was pretreated with hexamethonium (10 À4 mol·L À1 at the serosal side), a non-selective inhibitor of nicotinic receptors. Under these conditions, the nicotineinduced I sc was nearly suppressed (Table 2) . A weaker, but statistically significant, inhibition was observed in the presence of another inhibitor of nicotinic receptors, mecamylamine (10 À4 mol·L À1 at the serosal side; Table 2 ).
Vice versa, DMPP (10 À4 mol·L À1 at the serosal side), a chemically different nicotinic agonist, stimulated the current carried by the Na + -K + -pump ( Figure 5A ), an effect, which was suppressed by hexamethonium (10 À4 mol·L À1 at the serosal side; Figure 5B ).
Figure 2
Effect of nicotine (10 À4 mol . L À1 at the serosal side) in the presence of TTX (10 À6 mol . L À1 at the serosal side) on total current across the basolateral membrane (mucosal: 98 mmol·L À1 NaCl/13.5 mmol·L À1 KCl; serosal: 107 mmol·L À1 NaCl/4.5 mmol·L À1 KCl as indicated by the schematic inset).
The apical membrane was permeabilized by nystatin (100 μg·mL À1 at the mucosal side). Mucosa-submucosa preparations from rat distal colon.
Values are means ± SEM, n = 8.
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As several subunits of nicotinic receptors have been detected on the mRNA level in rat colonic epithelium (Bader and Diener, 2015) , which can be thought to form different combinations of functional nicotinic receptors, experiments with 'bona fide' subtype selective blockers of nicotinic receptors were performed (for references to the inhibitors used, see Chavez-Noriega et al., 1997, Wonnacott and Barik, 2007) . In the presence of strychnine (10 À5 mol·L À1 at the serosal side), which besides its well-known action on glycine receptors also blocks α7, α8 and α9α10-subunits of nicotinic receptors, the pump current induced by nicotine (10 À4 mol·L À1 at the serosal side) tended to be reduced, although this effect did not reach statistical significance (Table 2) . α-Bungarotoxin (10 À6 mol·L À1 at the serosal side), a blocker of of α7, α8 and α9*-subunits, was ineffective. In contrast, DhβE (10 À5 mol·L À1 at the serosal side), an inhibitor of, for example, α4β2 and α3β2 nicotinic receptors, and atropine (2.5·10 À5 mol·L À1 at the serosal side), which -in concentrations higher than those needed for muscarinic receptor blockade -inhibits, for example, α3β2, α3β4, α4β2 or α4β4 nicotinic receptors (Parker et al., 2003) , caused a significant inhibition of the nicotine-induced pump current (Table 2) . Inhibition amounted to about 35% in the case of DhβE and 45% in the case of atropine, that is, inhibition was incomplete.
As the blocking profiles of DhβE and atropine only partially overlap, we tested a combination of both receptor blockers, which might cause a stronger inhibition of the nicotine-induced pump current. This was indeed the case. When both inhibitors were combined, the nicotine-induced I sc was reduced by 60% in comparison with an untreated control group (Table 2) . Additional inclusion of strychnine in the blocker 'cocktail' did not enhance the inhibition ( Table 2 ), suggesting that, in contrast to atropine-and DhβE-sensitive nicotinic receptors, strychnine-sensitive nicotinic receptors are probably not involved in the stimulation of the pump current by epithelial nicotinic receptors. The solvents used for the solubilization of some of the blockers, that is, DMSO or ethanol, had no effect on the stimulation of the pump current by nicotine (Table 2) .
Despite the fact that all experiments were performed in the presence of TTX, which blocks the propagation of action potentials in neurons, there remains the possibility that nicotine stimulates presynaptic nicotinic receptors (Galligan, 1999) . Such a presynaptic effect would be insensitive to TTX. In order to block neurotransmitter release, two snail toxins, conotoxin MVIIC (a blocker of PQ-and N-type voltagedependent Ca 2+ channels) and conotoxin SVIB (a blocker of N-type voltage-dependent Ca 2+ channels), were used.
However, when the tissues were pretreated with a combination of both blockers (each in a concentration of 5 · 10 À8 mol·L À1 at the serosal side), the stimulation of the pump current was not inhibited (Table 2) , excluding the possibility that nicotine acts via presynaptic nicotinic receptors.
Potentiation of epithelial muscarinic and nicotinic receptor responses during induction of transepithelial Cl À secretion
The colonic epithelium expresses both muscarinic M 1 and M 3 receptors (Haberberger et al., 2006) as well as different subunits of nicotinic receptors (Bader and Diener, 2015 (n = 7) was induced by the muscarinic agonist pilocarpine in a concentration of 4·10 À6 mol·L À1 (at the serosal side). When both agonists were administered simultaneously, the amplitude of the stimulated I sc was about fourfold in comparison with the response to any one of these drugs, administered alone ( Figure 6 ). In other words, there was a synergistic action suggesting a potentiation of the effect of muscarinic and nicotinic receptor stimulation on transepithelial anion secretion. In order to establish the optimal concentration ratio of the nicotinic and the muscarinic agonists for potentiation of the secretory response, the nicotine concentration was fixed to 10 À6 mol·L À1 and the concentration of pilocarpine was varied from 2·10 À6 mol·L À1 to 5·10 À5 mol·L
À1
( Figure 6B ). Under these conditions, a maximal potentiation was observed for a ratio of nicotine : pilocarpine of 1:10, that is, 10 À6 mol·L À1 nicotine combined with 10 À5 mol·L À1 pilocarpine ( Figure 6B at the mucosal side). Mucosa-submucosa preparations from rat distal colon. Values are means ± SEM, n = 8 (each group), *P < 0.05, significantly different from extrapolated baseline. Effect of nicotine (10 À4 mol . L À1 at the serosal side) on the current across the basolateral membrane carried by the Na + -K + -ATPase, with or without antagonists of nicotinic receptors. The apical membrane was permeabilized with nystatin (100 μg·mL À1 at the mucosal side). The mucosal and the serosal solution was 107 mmol·L À1 NaCl/4.5 mmol·L À1 KCl (i.e. a missing K + concentration gradient prevented currents across basolateral K + channels).
Concentrations of inhibitors (all administered to the serosal side) were as follows: hexamethonium (10
and conotoxin SVIB (5 x·10 À8 mol·L À1 ). Furthermore, control experiments with the highest concentrations of the solvents DMSO (1 mL·L À1 ) and ethanol (0.5 mL·L À1 ) are shown. Values are given as difference to the extrapolated baseline current after administration of nystatin (ΔI sc ; see ) and are means ± SEM. *P < 0.05 significantly different from ΔI sc without inhibitor.
Figure 5
Effect of DMPP (10 À4 mol . L À1 at the serosal side) in the presence of TTX (10 À6 mol . L À1 at the serosal side) on current mediated by the Na + -K + -pump (mucosal and serosal: 107 mmol·L À1 NaCl/4.5 mmol·L À1 KCl as indicated by the schematic inset). The effect of DMPP was tested on the absence (A) and presence (B) of hexamethonium (10 À4 mol·L À1 at the serosal side). The apical membrane was permeabilized by nystatin (100 μg·mL À1 at the mucosal side). Mucosa-submucosa preparations from rat distal colon. Values are means ± SEM; n = 7 (each group), *P < 0.05, significantly different from extrapolated baseline.
Epithelial nicotinic receptors BJP presence of this inhibitor, the nicotine/pilocarpine mix induced an increase in I sc of only 0.29 ± 0.11 μEq·h À1 ·cm
À2
(n = 6) compared with 1.65 ± 0.45 μEq·h À1 ·cm À2 in the absence of bumetanide (n = 6, P < 0.05 vs. response in the presence of bumetanide).
Discussion
Nicotine receptors are not exclusively expressed by electrically excitable cells such as neurons or skeletal muscle fibres, but are found also in other tissues such as epithelia. For example, different subunits of these homo-or heteropentameric receptors have been found in epithelia in placenta (Lips et al., 2005) , trachea (Kummer et al., 2008) or skin (Wessler and Kirkpatrick, 2008) . They are not only involved in the regulation of physiological functions of the epithelium such as control of the production of airway lining fluid in the lung (Hollenhorst et al., 2012) but are thought to play also an important role under pathophysiological conditions such as tumour induction in the lung or in the gastrointestinal tract (Schuller, 2009 ).
The present results indicate a new mechanism of action by which epithelial nicotinic receptors, recently identified on the molecular and the functional level in rat colonic epithelium (Bader and Diener, 2015) , are involved in the control of colonic Cl À secretion. In contrast to stimulation of muscarinic receptors (Strabel and Diener, 1995, Hennig et al., 2008) , stimulation of epithelial nicotinic receptors evoked by nicotine (or DMPP) in the presence of TTX was not coupled to the opening of apical Cl À channels (Figure 1) or basolateral K + channels (Figure 3 ). Both were activated by an increase of the cytosolic Ca 2+ concentration evoked, for example, by carbachol (Lindqvist et al., 1998) . Also, an activation of apical Ca 2+ -dependent K + channels was not induced by nicotine (data not shown). Such an effect would, however, lead to a negative I sc as observed in the early phase of the carbachol-induced I sc response in rat colon (Schultheiss and Diener, 1997) , but might indirectly support anion secretion via maintenance of a negative membrane potential (Cook and Young, 1989) . Instead, the stimulation of anion secretion by nicotine takes place at the basolateral membrane ( Figure 3 ) and is caused by the activation of a Na + -dependent, scilliroside-and ouabain-sensitive (Table 1) current. Thus, nicotinic agonists such as nicotine (Figure 4 ) or DMPP ( Figure 5 ) activate the basolateral Na + -K + -pump.
The function of this ATPase in epithelia and other cells is to establish the central ion concentration gradients between the cytosol and the extracellular medium. The Na + concentration gradient establishes the driving force for the Na + -coupled secondary active transport of other solutes, whereas the K + gradient establishes the basal membrane potential due to diffusion of K + out of the cell via K + channels in the membrane. The Na + -K + -ATPase is composed of a combination of different isoforms of α-subunits, which contain the Na + -and K + -binding sites, and β-subunits, which function as chaperons. In epithelia, including that of rat colon, the dominant form of this enzyme is a α 1 β 1 heterodimer (Escoubet et al., 1997) . As a facultative component, the regulatory protein FXYD (with seven isoforms known up to now) is described, which seems, however, not to be essential for pump activity (Geering, 2005) . The α 1 subunit from rats is known to be about 100× less sensitive to ouabain (Blanco and Mercer, 1998) , the prototypical steroid blocking pump activity in most species, which explains the only incomplete inhibition of the nicotine-induced pump current by ouabain, whereas scilliroside, the most potent blocker of rat Na + -K + -ATPase (Robinson, 1970) , nearly abolished it (Table 1) . Different subunits of nicotinic receptors have been found when performing RT-PCR experiments starting with mRNA isolated from rat colonic crypts (Bader and Diener, 2015) . Therefore, inhibitor experiments were designed with subtype-selective inhibitors (for references to the inhibitors used, see Chavez-Noriega et al., 1997 , Parker et al., 2003 , Wonnacott and Barik, 2007 to find out which of the subunit combination(s) that can be thought to form functional nicotinic receptors might mediate the stimulation of the pump current measured in apically permeabilized colonic epithelium. α-Bungarotoxin (blocker of α7, α8 and α9α10 subunits of nicotinic receptors) was ineffective and also strychnine (blocker of α7, α8 and α9α10 subunits) did not diminish significantly the nicotine-induced pump current (Table 2 ). In contrast, DhβE (inhibitor of, e.g. α4β2 and α3β2 nicotinic receptors) and a high concentration of atropine (which inhibits, e.g. α3β2, α3β4, α4β2 or α4β4 nicotinic receptors; Parker et al., 2003) caused a significant inhibition of the nicotine-induced pump current (Table 2) . Inhibition was more effective, when both inhibitors were combined. If one does not assume insufficient concentrations to be responsible for the incomplete inhibition (which is, however, difficult to test because at higher concentrations subtype selectivity becomes less likely), this might indicate that more than one combination of the subunits found in rat colonic epithelium (α2, α4, α5, α6, α7, α10 and β4; Bader and Diener, 2015) participates in the regulation of pump activity.
The mode of action, how these epithelial nicotinic receptors are coupled to Na + -K + -ATPase, is not yet known.
Classically, nicotinic receptors are ligand-gated cation channels that open a non-selective cation channel as acetylcholine binds to a binding site formed by two neighbouring subunits (α1 to α7 and α9 on one side and α10, β3, β4, γ, δ or ε at the other side; Albuquerque et al., 2009) . However, also metabotropic effects of nicotinic receptors have been described (Grando, 2014) . One example for a cellular system in which the response evoked by nicotine is independent from cation flux into the cell is the hyperpolarization induced by nicotine at rat septal neurons. This response has been shown to be independent from the influx of extracellular Ca 2+ , but instead involves a G-protein (Sorenson and Gallagher, 1996) . A further example for metabotropic signalling via nicotinic receptors is the neuroprotective effect of nicotine on rat brain, which seems to involve the activation of phosphatidyl inositol-3-kinase (PI3K) and of the membrane-associated tyrosine kinase Src (Kihara et al., 2001) . So it remains to be determined whether in rat colonic epithelium nicotine acts via ionotropic receptors, that is, activates cation influx into the cell via ligand-gated ion channels, or involves metabotropic mechanism(s) of action. Interestingly, stimulation of sugar absorption in porcine jejunum by insulin-like growth factor 1 is caused by activation of the Na + -K + -pump and is mediated by a PI3 kinase (Alexander and Carey, 2001) . Also, the thyroid hormone, triiodothyronine, activates Na + -K + -pump activity in tracheal epithelium via non-genomic mechanisms involving Src und PI3-kinase (Bhargava et al., 2007) . Thus, there is an overlap of known metabotropic signalling cascades, which can be coupled to nicotinic receptors, with pathways involved in the control of Na + -K + -pump activity.
Whether these or other signalling cascades with known effects of the Na + -K + -ATPase such as changes in the phosphorylation level (Poulsen et al., 2010) or changes in redox state (Figtree et al., 2012) or other mechanisms mediate the coupling between nicotinic receptors and Na + -K + -pump activity in the colonic epithelium remains to be determined in future experiments. A further unknown parameter is the localization of nicotinic receptors within the epithelium, for example, the distribution between crypt and surface epithelium. This is, however, a challenging problem due to the lack of specific antibodies (see, e.g. Moser et al., 2007) .
Figure 7
Concentration-dependent effect of nicotine (green), pilocarpine (blue) and the combination of both (red) on transepithelial chloride secretion measured as increase in I sc (ΔI sc ) in intact epithelia. The agonists were administered at the serosal side. All experiments were performed in the presence of TTX (10 À6 mol·L À1 at the serosal side).
After each administration of an agonist (or of the agonist combination), the serosal compartment was washed three times with 5× the chamber volume, before the next concentration was administered. For graphical clarity, two of the three symbols for the same concentration(s) were laterally shifted to the right or the left, respectively, in order to avoid overlay of the data points. Values are given as increase in I sc (ΔI sc ) and are means ± SEM, n = 5 (nicotine), 6 (pilocarpine) and 8 (combination).
